Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference: Fireside Chat Scheduled for September 4, 2025

Harmony Biosciences will participate in the 2025 Cantor Global Healthcare Conference on September 4, 2025, with a fireside chat at 2:10 p.m. ET. The company will discuss its therapies for rare neurological diseases. The presentation will be webcast on the Harmony Biosciences investor page. Harmony Biosciences is a pharmaceutical company focused on developing innovative therapies for patients with rare neurological diseases.

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has announced that its management team will participate in a fireside chat at the 2025 Cantor Global Healthcare Conference in New York, New York, on Thursday, September 4, 2025, at 2:10 p.m. ET. The event is an opportunity for investors and healthcare professionals to engage with Harmony Biosciences' leadership and learn about the company's innovative therapies for rare neurological diseases.

The fireside chat will be webcast on the Harmony Biosciences investor page, allowing attendees to access the discussion remotely. Harmony Biosciences, established by Paragon Biosciences, LLC, in 2017, is dedicated to developing and commercializing therapies for patients with rare neurological diseases who have unmet medical needs. The company's focus on novel science, visionary thinking, and a commitment to those who feel overlooked has driven its mission to create a better future for these patients.

For more information about Harmony Biosciences and its upcoming fireside chat, visit www.harmonybiosciences.com. The webcast will be available on the company's investor page at https://ir.harmonybiosciences.com/.

References:
[1] https://www.marketscreener.com/news/harmony-biosciences-to-participate-in-2025-cantor-global-healthcare-conference-ce7c51d3de8bf023
[2] https://www.stocktitan.net/news/HRMY/harmony-biosciences-to-participate-in-2025-cantor-global-healthcare-upixqwr9bebd.html